Oliver Luxxe Assets’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Hold
3,200
0.04% 186
2026
Q1
$273K Hold
3,200
0.04% 187
2025
Q4
$253K Hold
3,200
0.04% 184
2025
Q3
$256K Hold
3,200
0.04% 177
2025
Q2
$291K Hold
3,200
0.05% 167
2025
Q1
$300K Sell
3,200
-3,200
-50% -$287K 0.06% 172
2024
Q4
$623K Buy
6,400
+3,200
+100% +$305K 0.06% 182
2024
Q3
$332K Sell
3,200
-60
-2% -$6.12K 0.06% 168
2024
Q2
$316K Buy
3,260
+60
+2% +$5.54K 0.07% 163
2024
Q1
$288K Sell
3,200
-10
-0.3% -$847 0.06% 162
2023
Q4
$256K Buy
3,210
+10
+0.3% +$752 0.06% 160
2023
Q3
$228K Hold
3,200
0.06% 155
2023
Q2
$247K Hold
3,200
0.06% 157
2023
Q1
$240K Hold
3,200
0.06% 163
2022
Q4
$252K Hold
3,200
0.07% 161
2022
Q3
$225K Sell
3,200
-45
-1% -$3.53K 0.07% 166
2022
Q2
$260K Buy
3,245
+45
+1% +$3.52K 0.08% 165
2022
Q1
$243K Hold
3,200
0.06% 184
2021
Q4
$273K Hold
3,200
0.07% 184
2021
Q3
$242K Hold
3,200
0.07% 186
2021
Q2
$260K Hold
3,200
0.07% 172
2021
Q1
$252K Hold
3,200
0.08% 159
2020
Q4
$263K Hold
3,200
0.08% 154
2020
Q3
$247K Buy
+3,200
New +$244K 0.09% 133

Other funds holding CL

Oliver Luxxe Assets's CL Position: Q2 2026 in Review

Oliver Luxxe Assets held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,200 shares worth $293K. The position accounts for 0.04% of the portfolio, ranked #186.

Oliver Luxxe Assets first reported a position in CL in Q3 2020 and has held it in 24 quarters since. The position peaked at $623K in Q4 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Oliver Luxxe Assets held 3,200 shares of Colgate-Palmolive worth $293K as of Q2 2026.
  • Oliver Luxxe Assets left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.04% of Oliver Luxxe Assets's portfolio in Q2 2026, its #186 holding.
  • Oliver Luxxe Assets first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 24 quarters since.
  • Oliver Luxxe Assets's Colgate-Palmolive position peaked at $623K in Q4 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.